Castle Biosciences CSTL Return on equity

Return on equity at other companies

Labcorp HoldingsLH

11.7%+2.5pp

VeracyteVCYT

6.9%+4.1pp

Lucid DiagnosticsLUCD

-710.6%—

Myriad GeneticsMYGN

-76.7%-98.4pp

Personalis, Inc.PSNL

-41.4%-6.7pp

NeoGenomicsNEO

-6.3%-2.0pp

FAQ

What is Castle Biosciences's return on equity?

Castle Biosciences (CSTL) reported return on equity of -2.8% in Q1 2026.

How has Castle Biosciences's return on equity changed year-over-year?

Castle Biosciences's return on equity decreased by 136.6% year-over-year, from -1.2% to -2.8%.

What is the long-term trend for Castle Biosciences's return on equity?

Over 5 years (2020 to 2025), Castle Biosciences's return on equity has grown at a 4.9% compound annual growth rate (CAGR), from -4.1% to -5.2%.

What does return on equity mean?

Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.